Khosla Ventures Acquisition Co.
KVSA
NASDAQ Capital Market10.74
USD
+0.01
- -
CIK
0001841873
ISIN
US4825041076
CUSIP
482504107
Return %
Stock
S&P500
1Y
6.73
18.21
3Y
4.75
64.38
5Y
4.75
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Samir Kaul
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2128 Sand Hill Road Menlo Park CA United States of America 94025
- IPO Date
- Mar 4, 2021
- CIK
- 0001841873
- Similar Companies
- Business
- Khosla Ventures Acquisition Co. is a blank check company based in Menlo Park, California, founded in 2021. Its primary business focus is to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with high-growth businesses. The company operates as a special purpose acquisition company (SPAC) affiliated with Khosla Ventures, a venture capital firm known for early-stage investments in sectors such as consumer, enterprise, financial services, health, artificial intelligence, agriculture/food, sustainable energy, space, 3D printing, virtual/augmented reality, and robotics. The company’s main functions involve identifying and partnering with private companies to facilitate their transition to public markets. As a SPAC, Khosla Ventures Acquisition Co. does not produce or sell physical products but provides capital and strategic guidance to innovative technology-driven firms across various industries. Khosla Ventures Acquisition Co.'s strategic initiatives connect it to the broader Khosla Ventures ecosystem, which focuses on breakthrough technologies and transformative sectors. Recent major changes include the termination of a planned business combination agreement with Valo Health in 2021 due to unfavorable market conditions within the biotechnology sector. Previously, KVSA had announced intentions to transfer its stock listing from Nasdaq to the New York Stock Exchange following the proposed merger with Valo Health, a company specialized in transforming drug discovery through AI-driven data. The failure to complete the merger and the subsequent winding down of operations mark significant recent operational developments for KVSA. The company also announced a redemption of all outstanding Class A common shares as part of its operational wind-down. Khosla Ventures Acquisition Co. is part of the broader Khosla Ventures network founded in 2004 by Vinod Khosla, specializing in venture capital investments across multiple high-growth sectors primarily in the United States. The firm has a notable portfolio that includes investments in advanced technology companies in AI, health, sustainability, and frontier technologies. Khosla Ventures Acquisition Co. continues to pursue opportunities consistent with Khosla Ventures' mission to support innovative entrepreneurs addressing large market opportunities with proprietary technology. In summary, Khosla Ventures Acquisition Co. functions as a SPAC established to facilitate mergers and acquisitions in high-growth industries, mostly technology-driven, headquartered in Menlo Park, California, with significant recent operational changes marked by the termination of a key merger agreement and a public shareholder redemption process in progress.
Khosla Ventures Acquisition Co. Announces Redemption of Public Shares and Subsequent Dissolution
Here's why sodium-ion batteries are shaping up to be a big technology breakthrough
Khosla Ventures/Valo Health De-SPAC: Heed The Sponsor's Advice And Stay Away
Valo Health To Combine With Vinod Khosla-Backed SPAC In $2.8B Deal
The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition